Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

bethamethasone sodium phosphate 0.1% w/v, neomycin sulphate 0.5%w/v

Kenya - English - Pharmacy and Poisons Board

atco laboratories limited b-18 s.i.t.e. karachi 75700 pakistan. - betamethasone sodium phosphate neomycin sulphate - ear/eye/nasal drops, solution - 0.1% w/v 0.5% w/v - ophthalmological and otological preparation:

Kenya - English - Pharmacy and Poisons Board

atco laboratories limited b-18 s.i.t.e. karachi 75700 pakistan. - betamethasone sodium phosphate neomycin sulphate - ointment - 0.1% w/v 0.5% w/v - ophthalmological anti-infectives: antibiotics

Canada - English - Health Canada

allergan inc - levobunolol hydrochloride; dipivefrin hydrochloride - liquid - 0.5%; 0.1% - levobunolol hydrochloride 0.5%; dipivefrin hydrochloride 0.1% - mydriatics

Tanzania - English - Tanzania Medicinces & Medical Devices Authority

atco laboratories limited, pakistan - betamethasone , antibiotics - drops - 105 mg/100ml + 0.525 mg/100ml

Uganda - English - National Drug Authority

royal group - betamethasone + neomycin - ophthalmic drops - 0.1%w/v+0.5%w/v

Kenya - English - Pharmacy and Poisons Board

atco laboratories limited b-18 s.i.t.e. karachi 75700 pakistan. - betamethasone sodium phosphate - ear/eye/nasal drops, solution - 0.1% w/v - ophthalmologicals: corticosteroids

United States - English - myHealthbox

ecolab -

United States - English - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - probenecid (unii: po572z7917) (probenecid - unii:po572z7917) - probenecid 500 mg - probenecid tablets are indicated for the treatment of the hyperuricemia associated with gout and gouty arthritis. as an adjuvant to therapy with penicillin or with ampicillin, methicillin, oxacillin, cloxacillin, or nafcillin, for elevation and prolongation of plasma levels by whatever route the antibiotic is given. hypersensitivity to probenecid. children under 2 years of age. not recommended in persons with known blood dyscrasias or uric acid kidney stones. therapy with probenecid should not be started until an acute gouty attack has subsided.

United States - English - NLM (National Library of Medicine)

marlex pharmaceuticals inc - probenecid (unii: po572z7917) (probenecid - unii:po572z7917) - probenecid 500 mg - probenecid tablets are indicated for the treatment of the hyperuricemia associated with gout and gouty arthritis. as an adjuvant to therapy with penicillin or with ampicillin, methicillin, oxacillin, cloxacillin, or nafcillin, for elevation and prolongation of plasma levels by whatever route the antibiotic is given. hypersensitivity to probenecid. children under 2 years of age. not recommended in persons with known blood dyscrasias or uric acid kidney stones. therapy with probenecid should not be started until an acute gouty attack has subsided.